The global market for Human Enzyme Linked Immunosorbent Assay (ELISA) Kit was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The human enzyme linked immunosorbent assay (ELISA) kit a quick, convenient, and accurate research tool for the detection and quantitation of targets of interest in cultures and samples.
North American market for Human Enzyme Linked Immunosorbent Assay (ELISA) Kit is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human Enzyme Linked Immunosorbent Assay (ELISA) Kit is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Human Enzyme Linked Immunosorbent Assay (ELISA) Kit include CUSABIO, Cayman Chemical, Merck, R&D Systems, Chondrex, Abcam, Millipore, Life Diagnostics, Active Motif, Enzo, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Human Enzyme Linked Immunosorbent Assay (ELISA) Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Enzyme Linked Immunosorbent Assay (ELISA) Kit.
The Human Enzyme Linked Immunosorbent Assay (ELISA) Kit market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Enzyme Linked Immunosorbent Assay (ELISA) Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
CUSABIO
Cayman Chemical
Merck
R&D Systems
Chondrex
Abcam
Millipore
Life Diagnostics
Active Motif
Enzo
Adipogen
Mabtech
Demeditec
Peprotech
Jiangsu Meimian Industrial
Shanghai Jianglai Biology
Segment by Type
Human Heparin (Hep) Antibody (IgG)
Human Ganglioside D1b (GD1b) Antibody (IgG)
Human Myeloid-derived Growth Factor (MYDGF)
Human Enterovirus 71 Virus (EV71) Antibody (IgG)
Human Keyhole Limpet Hemocyanin Antibody(Ig锛�)
Segment by Application
Cancer Research
Cardiovascular Research
Cell Biology Research
Epigenetics Research
Immunology Research
Neuroscience Research
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Enzyme Linked Immunosorbent Assay (ELISA) Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Enzyme Linked Immunosorbent Assay (ELISA) Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Overview
1.1 Product Definition
1.2 Human Enzyme Linked Immunosorbent Assay (ELISA) Kit by Type
1.2.1 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Human Heparin (Hep) Antibody (IgG)
1.2.3 Human Ganglioside D1b (GD1b) Antibody (IgG)
1.2.4 Human Myeloid-derived Growth Factor (MYDGF)
1.2.5 Human Enterovirus 71 Virus (EV71) Antibody (IgG)
1.2.6 Human Keyhole Limpet Hemocyanin Antibody(Ig锛�)
1.3 Human Enzyme Linked Immunosorbent Assay (ELISA) Kit by Application
1.3.1 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Cancer Research
1.3.3 Cardiovascular Research
1.3.4 Cell Biology Research
1.3.5 Epigenetics Research
1.3.6 Immunology Research
1.3.7 Neuroscience Research
1.3.8 Others
1.4 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Revenue 2020-2031
1.4.2 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales 2020-2031
1.4.3 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Competition by Manufacturers
2.1 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Enzyme Linked Immunosorbent Assay (ELISA) Kit, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Enzyme Linked Immunosorbent Assay (ELISA) Kit, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Enzyme Linked Immunosorbent Assay (ELISA) Kit, Product Type & Application
2.7 Global Key Manufacturers of Human Enzyme Linked Immunosorbent Assay (ELISA) Kit, Date of Enter into This Industry
2.8 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Competitive Situation and Trends
2.8.1 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Players 麻豆原创 Share by Revenue
2.8.3 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Scenario by Region
3.1 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales by Region: 2020-2031
3.2.1 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales by Region: 2020-2025
3.2.2 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales by Region: 2026-2031
3.3 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Revenue by Region: 2020-2031
3.3.1 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Revenue by Region: 2020-2025
3.3.2 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Revenue by Region: 2026-2031
3.4 North America Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Facts & Figures by Country
3.4.1 North America Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales by Country (2020-2031)
3.4.3 North America Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Facts & Figures by Country
3.5.1 Europe Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales by Country (2020-2031)
3.5.3 Europe Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales by Country (2020-2031)
3.7.3 Latin America Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales by Type (2020-2031)
4.1.1 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales by Type (2020-2025)
4.1.2 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales by Type (2026-2031)
4.1.3 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Revenue by Type (2020-2031)
4.2.1 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Revenue by Type (2020-2025)
4.2.2 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Revenue by Type (2026-2031)
4.2.3 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales by Application (2020-2031)
5.1.1 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales by Application (2020-2025)
5.1.2 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales by Application (2026-2031)
5.1.3 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Revenue by Application (2020-2031)
5.2.1 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Revenue by Application (2020-2025)
5.2.2 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Revenue by Application (2026-2031)
5.2.3 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CUSABIO
6.1.1 CUSABIO Company Information
6.1.2 CUSABIO Description and Business Overview
6.1.3 CUSABIO Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CUSABIO Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Product Portfolio
6.1.5 CUSABIO Recent Developments/Updates
6.2 Cayman Chemical
6.2.1 Cayman Chemical Company Information
6.2.2 Cayman Chemical Description and Business Overview
6.2.3 Cayman Chemical Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Cayman Chemical Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Product Portfolio
6.2.5 Cayman Chemical Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 R&D Systems
6.4.1 R&D Systems Company Information
6.4.2 R&D Systems Description and Business Overview
6.4.3 R&D Systems Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales, Revenue and Gross Margin (2020-2025)
6.4.4 R&D Systems Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Product Portfolio
6.4.5 R&D Systems Recent Developments/Updates
6.5 Chondrex
6.5.1 Chondrex Company Information
6.5.2 Chondrex Description and Business Overview
6.5.3 Chondrex Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Chondrex Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Product Portfolio
6.5.5 Chondrex Recent Developments/Updates
6.6 Abcam
6.6.1 Abcam Company Information
6.6.2 Abcam Description and Business Overview
6.6.3 Abcam Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Abcam Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Product Portfolio
6.6.5 Abcam Recent Developments/Updates
6.7 Millipore
6.7.1 Millipore Company Information
6.7.2 Millipore Description and Business Overview
6.7.3 Millipore Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Millipore Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Product Portfolio
6.7.5 Millipore Recent Developments/Updates
6.8 Life Diagnostics
6.8.1 Life Diagnostics Company Information
6.8.2 Life Diagnostics Description and Business Overview
6.8.3 Life Diagnostics Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Life Diagnostics Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Product Portfolio
6.8.5 Life Diagnostics Recent Developments/Updates
6.9 Active Motif
6.9.1 Active Motif Company Information
6.9.2 Active Motif Description and Business Overview
6.9.3 Active Motif Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Active Motif Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Product Portfolio
6.9.5 Active Motif Recent Developments/Updates
6.10 Enzo
6.10.1 Enzo Company Information
6.10.2 Enzo Description and Business Overview
6.10.3 Enzo Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Enzo Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Product Portfolio
6.10.5 Enzo Recent Developments/Updates
6.11 Adipogen
6.11.1 Adipogen Company Information
6.11.2 Adipogen Description and Business Overview
6.11.3 Adipogen Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Adipogen Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Product Portfolio
6.11.5 Adipogen Recent Developments/Updates
6.12 Mabtech
6.12.1 Mabtech Company Information
6.12.2 Mabtech Description and Business Overview
6.12.3 Mabtech Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Mabtech Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Product Portfolio
6.12.5 Mabtech Recent Developments/Updates
6.13 Demeditec
6.13.1 Demeditec Company Information
6.13.2 Demeditec Description and Business Overview
6.13.3 Demeditec Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Demeditec Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Product Portfolio
6.13.5 Demeditec Recent Developments/Updates
6.14 Peprotech
6.14.1 Peprotech Company Information
6.14.2 Peprotech Description and Business Overview
6.14.3 Peprotech Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Peprotech Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Product Portfolio
6.14.5 Peprotech Recent Developments/Updates
6.15 Jiangsu Meimian Industrial
6.15.1 Jiangsu Meimian Industrial Company Information
6.15.2 Jiangsu Meimian Industrial Description and Business Overview
6.15.3 Jiangsu Meimian Industrial Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Jiangsu Meimian Industrial Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Product Portfolio
6.15.5 Jiangsu Meimian Industrial Recent Developments/Updates
6.16 Shanghai Jianglai Biology
6.16.1 Shanghai Jianglai Biology Company Information
6.16.2 Shanghai Jianglai Biology Description and Business Overview
6.16.3 Shanghai Jianglai Biology Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Shanghai Jianglai Biology Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Product Portfolio
6.16.5 Shanghai Jianglai Biology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Industry Chain Analysis
7.2 Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Production Mode & Process Analysis
7.4 Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales and 麻豆原创ing
7.4.1 Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Sales Channels
7.4.2 Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Distributors
7.5 Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Customer Analysis
8 Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Dynamics
8.1 Human Enzyme Linked Immunosorbent Assay (ELISA) Kit Industry Trends
8.2 Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Drivers
8.3 Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Challenges
8.4 Human Enzyme Linked Immunosorbent Assay (ELISA) Kit 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
CUSABIO
Cayman Chemical
Merck
R&D Systems
Chondrex
Abcam
Millipore
Life Diagnostics
Active Motif
Enzo
Adipogen
Mabtech
Demeditec
Peprotech
Jiangsu Meimian Industrial
Shanghai Jianglai Biology
听
听
*If Applicable.
